Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
7.23
+0.10 (1.40%)
Oct 6, 2026, 12:48 PM EDT - Market open
Artiva Biotherapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
115
Market Cap
353.48M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 251.00K | -33.24M | -99.25% |
| Dec 31, 2023 | 33.49M | 28.56M | 579.21% |
| Dec 31, 2022 | 4.93M | 2.93M | 146.30% |
| Dec 31, 2021 | 2.00M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Fennec Pharmaceuticals | 59.22M |
| Orchestra BioMed Holdings | 31.98M |
| Arcturus Therapeutics Holdings | 29.37M |
| Surrozen | 11.51M |
| Ocugen | 4.58M |
| Inhibikase Therapeutics | 1.00 |
ARTV News
- 4 days ago - Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026 - GlobeNewsWire
- 5 days ago - Artiva updates safety, translational data for AlloNK with rituximab - TheFly
- 5 days ago - Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren's Disease (ISSjD 2026) - GlobeNewsWire
- 12 days ago - Artiva Biotherapeutics Transcript: Stifel 2026 Virtual Immunology and Inflammation Forum - Transcripts
- 13 days ago - Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren's Disease - GlobeNewsWire
- 19 days ago - Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum - GlobeNewsWire
- 21 days ago - Artiva Biotherapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 27 days ago - Artiva Biotherapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts